Company Filing History:
Years Active: 1991
Title: Hanrik Clausen: Innovator in Monoclonal Antibody Research
Introduction
Hanrik Clausen is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies.
Latest Patents
Clausen holds a patent for a monoclonal antibody panel for blood group A antigen. This patent, which includes monoclonal antibodies HT29-36, CB, CLH6, M2, and S12, is instrumental in determining the presence of Type A blood group antigen. The antibodies are particularly useful in distinguishing different forms of this antigen, which can exhibit several variations. This innovation has potential applications in cancer diagnosis and related fields.
Career Highlights
Hanrik Clausen is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance his research in cancer diagnostics. His work has been pivotal in enhancing the understanding of blood group antigens and their implications in medical science.
Collaborations
Clausen has collaborated with esteemed colleagues such as Koichi Furukawa and Sen-Itiroh Hakomori. These partnerships have fostered a collaborative environment that promotes innovative research and development in the field.
Conclusion
Hanrik Clausen's contributions to monoclonal antibody research exemplify the impact of innovation in medical science. His work not only advances our understanding of blood group antigens but also holds promise for future applications in cancer diagnosis.